Delivering Patient Data through a Regulated Platform to Improve Trial Oversight, Upcoming Webinar Hosted by Xtalks - EIN Presswire

2022-08-20 01:08:29 By : Ms. Tina Zhou

There were 1,086 press releases posted in the last 24 hours and 219,893 in the last 365 days.

In this free webinar, learn how one can increase operational efficiencies and enhance the patient experience in clinical trials. Attendees will learn why the industry has moved towards patient-centric data collection. The featured speakers will discuss the benefits of a clinical platform approach over siloed solutions and how to use these best practices to drive future decision-making.

Patient-centric designs allow users to better engage and participate in a familiar environment. The rapid growth of patient-centric trials has served as a catalyst for the development of new, minimally invasive ways to collect high-quality clinical patient data. This demand combined with the growing evidence around the benefits of automated data qualification and aggregated data streams, has empowered the accelerated growth of connected sensors and wearables in clinical research.

The result? Sponsors and CROs can now review real-world insights, which can be further analyzed to identify trends, establish correlations with greater confidence and generate more actionable clinical insights.

However, to deliver this potential, a unique blend of processes and technology is needed within a regulated and unified clinical platform.

Taking data streams through patient-centric design allows users to better engage and participate in a familiar environment and removes many of the manual steps in traditional research.

In this webinar, the featured panel of clinicians and technology leaders will discuss: How one can increase operational efficiencies and enhance the patient experience in clinical trials; Why the industry has moved towards patient-centric data collection; The benefits of a clinical platform approach over siloed solutions; How to use these best practices to drive future decision-making.

Join this webinar to learn about unlocking better patient outcomes, more actionable insights and enhanced real-world patient data through a regulated platform.

Join experts from Medable, Gillian Livock, SVP & GM Digital Measures; and from Withings, Antoine Pivron, Head of Health Solutions – EMEA, for the live webinar on Wednesday, September 7, 2022, at 11am EDT (4pm BST/UK).

For more information, or to register for this event, visit Delivering Patient Data through a Regulated Platform to Improve Trial Oversight.

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Contact: Vera Kovacevic Tel: +1 (416) 977-6555 x371 Email: vkovacevic@xtalks.com

For the original version on PRWeb visit: https://www.prweb.com/releases/delivering_patient_data_through_a_regulated_platform_to_improve_trial_oversight_upcoming_webinar_hosted_by_xtalks/prweb18845572.htm

EIN Presswire's priority is source transparency. We do not allow opaque clients, and our editors try to be careful about weeding out false and misleading content. As a user, if you see something we have missed, please do bring it to our attention. Your help is welcome. EIN Presswire, Everyone's Internet News Presswire™, tries to define some of the boundaries that are reasonable in today's world. Please see our Editorial Guidelines for more information.

© 1995-2022 Newsmatics Inc. dba EIN Presswire All Right Reserved.